Feb 23, 2026

An analysis published by StockStory examined the growth prospects of large-capitalization stocks, noting their stability but also the challenge of sustaining high growth after capturing large market shares. The source identified two such stocks with potential upside and one with concerning outlooks.

Stock Considered for Selling

Bristol-Myers Squibb, with a market capitalization of $123.5 billion, is a pharmaceutical company founded in 1887. The company, which underwent a merger in 1989, develops and markets prescription drugs for serious conditions like cancer and cardiovascular disease. The analysis expresses wariness due to its five-year average annual revenue growth of only 2.6%, a…